Ultrasound technique to evaluate solid pancreatic masses
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study is looking at a special ultrasound technique (called EUS-DFI) to better examine solid masses in the pancreas. It may help doctors tell if these masses are benign or cancerous.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a solid (not fluid-filled) mass in your pancreas.
- You must be able to understand the study and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of needles used during an endoscopic ultrasound to sample solid masses. It aims to see which method gets better tissue for diagnosis.
This trial is testing an artificial intelligence (AI) system that helps doctors identify solid masses in the pancreas using images from a special endoscope (endoscopic ultrasound). The goal is to see if the AI can make a more accurate diagnosis than the standard approach.
This study tests two new ultrasound techniques to better tell apart pancreatic cancer from other solid growths in the pancreas. If you have a solid pancreas mass, the results could help doctors choose the most appropriate treatment without unnecessary surgery.
This trial tests a new approach that combines a special biopsy needle with immediate on-site checking to better diagnose solid pancreas masses. It may help get a clearer diagnosis in one procedure.
This study uses blood taken from a vein to build and check diagnostic models for pancreatic cancer. It may help doctors identify pancreatic cancer more accurately in people who have a suspected mass on imaging.
This trial compares two ways to look at a spot on the pancreas: a special CT scan (triphasic CT) and a procedure called endoscopic ultrasound with biopsy (EUS-FNB). The goal is to see which method better identifies the type of lesion, helping doctors choose the best treatment.
Hear when a new Pancreatic Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.